Investigational Blood Test Detects ALS Up to 10 Years Before Symptoms Appear
Johns Hopkins-led study identifies protein signature with 98% accuracy in distinguishing ALS patients from healthy individuals and those with other neurological diseases.
Johns Hopkins-led study identifies protein signature with 98% accuracy in distinguishing ALS patients from healthy individuals and those with other neurological diseases.
The acquisition strengthens Tempus' multimodal platform with advanced AI-powered pathology solutions for clinical laboratories and healthcare providers.
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
The newly appointed scientific and medical experts will guide product development, research, regulatory planning, and commercialization.
The platform aims to offer more consistent and precise characterization at diagnosis and tracking of fibrosis in patients with metabolic dysfunction-associated steatohepatitis.Â
As labs aim to minimize disruptions, they are increasingly investing in strategies focused on resilience and rapid recovery.
Company sees back-to-back record months in June and July, reaffirms forecast of 3X year-over-year revenue growth for noninvasive lung cancer diagnostic.
The Oak Ridge, Tennessee-based company's next-generation analyzer delivers results three times faster than its predecessor while maintaining laboratory-grade diagnostic precision.
UK diagnostics developer signs with multi-site laboratory group to scale commercial launch of early-stage lung cancer biomarker test across the United States.
New research suggests standard drug tests may miss low-level exposure in children—potentially sending them back into unsafe home environments—and suggests an alternative.
Bruker's MALDI Biotyper sirius and sirius one systems have received the ACT Label from My Green Lab, recognizing responsible design.
Researchers have developed a new AI method that significantly improves the reliability and accuracy of AI tools for clinical applications.
Labcorp and NOWDiagnostics have partnered to distribute free First to Know Syphilis Test kits to public health organizations nationwide.
Many clinical laboratories are using outdated urine analyzers, which may affect efficiency and data accuracy.